Softwr

Research · head to head

Genedata vs LabWare

Genedata logo

Genedata

Research

Enterprise R&D data platforms for biologics, screening and bioprocess, owned by Danaher

From
On request
Rated
-
Full reviewWebsite
LabWare logo

LabWare

Research

Enterprise laboratory information management system for regulated labs

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Genedata there is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.; LabWare implementation and validation take a year or more, and the services cost frequently exceeds the licence
  • They diverge on capability: Genedata covers Screener, LabWare covers Sample management.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Genedata and LabWare actually diverge.

Attributes where Genedata and LabWare differ
AttributeGenedataLabWare
PlatformsWeb, On-premise, Private cloudWindows, Web, Cloud, On-premise

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Genedata

  • Screener
  • Biologics
  • Bioprocess
  • Expressionist
  • Selector
  • Profiler
  • GxP-capable deployments

Only in LabWare

  • Sample management
  • Regulatory compliance
  • Stability studies
  • ELN
  • Configuration framework

Both cover

  • Instrument integration

What people use each for

The jobs each tool is most often brought in to do.

Genedata

  • A pharmaceutical screening group processing thousands of plates a week where manual QC and curve fitting no longer scalenot LabWare
  • A biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheetsnot LabWare
  • A process development group standardising bioprocess run data across sites for modelling and scale-upnot LabWare
  • A CRO delivering high-throughput screening results to sponsors that require documented, reproducible analysis pipelinesnot LabWare

LabWare

  • Pharmaceutical quality control laboratories subject to regulatory inspectionnot Genedata
  • Multi-site laboratory networks needing one method and specification librarynot Genedata
  • Contract laboratories managing chain of custody across many clientsnot Genedata
  • Laboratories replacing a validated legacy LIMS they can no longer maintainnot Genedata

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Genedata

  • There is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.
  • Platforms are licensed individually and most organisations need two or three, so the real contract is a sum of separate licences plus the integration work between them.
  • Deployment is a services programme rather than an installation, running months and requiring scientific configuration by the vendor, which means value arrives long after the first invoice.
  • Danaher ownership since 2023 gives the roadmap a natural pull toward Danaher instrument and bioprocessing lines, which is an advantage on that hardware and a question to ask if your instrument estate is from competitors.
  • Validated deployments for regulated use add scope, cost and an ongoing revalidation obligation on your side after each vendor release, and that recurring internal effort is rarely counted in the business case.

LabWare

  • Implementation and validation take a year or more, and the services cost frequently exceeds the licence
  • Pricing is entirely quote-based with no public reference point, even by enterprise standards
  • Extensive configuration means the finished system depends heavily on implementation quality, and outcomes vary widely between customers
  • The interface is functional rather than modern, which is a common objection from scientists used to consumer software
  • Substantially over-specified for research laboratories without regulatory obligations

Pricing, plan by plan

Genedata

On request
  • Genedata platform licence$undefined/year
    • Each platform, such as Screener or Biologics, licensed separately
    • Annual enterprise subscription scoped on users, sites and data volume
    • Implementation and scientific configuration services quoted as a separate programme

LabWare

On request
  • LabWare LIMS$undefined/year
    • Sample management
    • Instrument integration
    • Regulatory compliance

Which should you pick?

Choose Genedata if

  • You need screener.
  • You work on Web, On-premise, Private cloud.
  • You also want biologics.
Genedata review

Choose LabWare if

  • You need sample management.
  • You work on Windows, Web, Cloud, On-premise.
  • You also want regulatory compliance.
LabWare review

Questions people ask

Is Genedata or LabWare better?
Neither clearly leads. Genedata starts at On request and LabWare at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Genedata or LabWare?
Genedata starts at On request and LabWare at On request.
Does Genedata or LabWare run on more platforms?
Genedata runs on Web, On-premise, Private cloud. LabWare runs on Windows, Web, Cloud, On-premise.
What is Genedata best used for?
Genedata is most often used for a pharmaceutical screening group processing thousands of plates a week where manual qc and curve fitting no longer scale, a biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheets, a process development group standardising bioprocess run data across sites for modelling and scale-up, a cro delivering high-throughput screening results to sponsors that require documented, reproducible analysis pipelines. Of those, a pharmaceutical screening group processing thousands of plates a week where manual qc and curve fitting no longer scale and a biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheets are not what LabWare is typically brought in for.
What can Genedata do that LabWare cannot?
Genedata covers Screener, Biologics, Bioprocess, Expressionist. LabWare covers Sample management, Regulatory compliance, Stability studies, ELN. Both handle Instrument integration.

Answered from the vendors’ own pages

Genedata: Who owns Genedata?

Danaher acquired the company in 2023. It remains headquartered in Basel and continues under the Genedata name.

LabWare: Why is LabWare so dominant in pharma?

Validation experience. In a regulated laboratory the software forms part of what an inspector examines, and decades of accumulated validation practice is not something a newer vendor can substitute for.

Genedata: Is there a small-team or starter option?

No. Everything is an enterprise contract scoped by users, sites and data volume, with services attached.

LabWare: What does it cost?

Not published. Enterprise licensing plus implementation and validation services, and the services frequently exceed the licence.

Genedata: Do I buy one product or the whole suite?

Each platform is licensed separately. Most customers license two or three and integrate between them.

LabWare: How long is implementation?

A year or more for a regulated laboratory, including validation. Anyone quoting substantially less is either scoping narrowly or omitting validation.

Genedata: Can it be used in a GxP environment?

Yes, with a validated deployment contracted as additional scope. Ongoing revalidation after releases remains your responsibility.

LabWare: Does it include an electronic laboratory notebook?

Yes, LabWare offers ELN alongside LIMS on the same platform, which avoids the integration problem of running two vendors.

LabWare: Is it suitable for a research lab?

Usually not. Research laboratories without regulatory obligations pay for compliance machinery they do not need, and Benchling or a lighter LIMS fits better.

Share

Related pages

More on Genedata

More on LabWare

Keep looking

Other head to heads